MARKET

ANGO

ANGO

AngioDynamics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.55
+0.47
+2.23%
After Hours: 21.55 0 0.00% 16:00 03/03 EST
OPEN
21.20
PREV CLOSE
21.08
HIGH
21.83
LOW
20.67
VOLUME
203.51K
TURNOVER
--
52 WEEK HIGH
22.19
52 WEEK LOW
7.48
MARKET CAP
818.12M
P/E (TTM)
-4.7900
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates
Veeva Systems' (VEEV) core Subscription business and Professional Service segments perform impressively in fiscal Q4.
Zacks · 3h ago
Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y
Zacks.com · 6h ago
Hologic (HOLX) Boosts Diagnostics Portfolio With New Buyout
Zacks.com · 1d ago
AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Tr...
Business Wire · 2d ago
DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates
Zacks · 2d ago
PRA Health (PRAH) Stock Down 2.8% Despite Q4 Earnings Beat
PRA Health's (PRAH) Data Solutions and Clinical Research segments put up a strong performance in the fourth quarter.
Zacks · 2d ago
LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss
Zacks.com · 5d ago
Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates
Zacks.com · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ANGO. Analyze the recent business situations of AngioDynamics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ANGO stock price target is 21.00 with a high estimate of 24.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 271
Institutional Holdings: 38.56M
% Owned: 101.56%
Shares Outstanding: 37.96M
TypeInstitutionsShares
Increased
39
1.92M
New
35
250.44K
Decreased
59
2.49M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.50%
Healthcare Equipment & Supplies
-2.57%
Key Executives
Chairman/Independent Director
Howard Donnelly
President/Chief Executive Officer/Director
James Clemmer
Chief Financial Officer/Executive Vice President/IR Contact Officer
Stephen Trowbridge
Senior Vice President/General Counsel/Secretary
Richard Rosenzweig
Senior Vice President/General Manager
Brent Boucher
Senior Vice President/General Manager
Chad Campbell
Senior Vice President/General Manager
Scott Centea
Senior Vice President/Director of Human Resources
Marna Bronfen-Moore
Senior Vice President
Benjamin Davis
Senior Vice President
David Helsel
Senior Vice President
Warren Nighan
Senior Vice President
Kim Seabury
Other
Juan Serna
Independent Director
Eileen Auen
Independent Director
Wesley Johnson
Independent Director
Karen Licitra
Independent Director
Dennis Meteny
Independent Director
Jan Reed
Independent Director
Michael Tarnoff
  • Dividends
  • Splits
  • Insider Activity
No Data
About ANGO
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.